Rilonacept
Top View
- Injections: Drugs NR Policy
- Research in Your Backyard Developing Cures, Creating Jobs
- CDER List of Licensed Biological Products With
- (INN) for Biological and Biotechnological Substances
- COVID19 As Immunology Boot Camp: Anti-Viral Defense, Cytokine Biology & Prospects for Therapy
- Arcalyst® (Rilonacept)
- Annual Report 2
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- EMEA Annual Report 2007 EMEA/MB/17464/2008 2.4, CURRENT Page 2/138 6
- FDA Approval of ARCALYST® (Rilonacept) for Recurrent Pericarditis
- Who Drug Information
- Arcalyst (Rilonacept)
- C9050 Injection, Emapalumab-Lzsg, 1 Mg C9122
- Changes Highlighted Final Version Date of Issue
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- Pharmaabkommen A1 E
- (12) United States Patent (10) Patent No.: US 9.295,731 B2 Nguyen (45) Date of Patent: Mar
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019